GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IMBdx Inc (XKRX:461030) » Definitions » Sale Of Business

IMBdx (XKRX:461030) Sale Of Business : ₩0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is IMBdx Sale Of Business?

IMBdx's sale of business for the three months ended in Mar. 2024 was ₩0 Mil. It means IMBdx gained ₩0 Mil from selling business. IMBdx's sale of business for the trailing twelve months (TTM) ended in Mar. 2024 was ₩0 Mil.

Compared with last quarter (₩0 Mil in Dec. 2023 ), IMBdx gained the same money from selling business in Mar. 2024 (₩0 Mil).


IMBdx Sale Of Business Historical Data

The historical data trend for IMBdx's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMBdx Sale Of Business Chart

IMBdx Annual Data
Trend Dec21 Dec22 Dec23
Sale Of Business
- - -

IMBdx Quarterly Data
Dec22 Mar23 Sep23 Dec23 Mar24
Sale Of Business - - - - -

IMBdx Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IMBdx Sale Of Business Related Terms

Thank you for viewing the detailed overview of IMBdx's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


IMBdx Business Description

Traded in Other Exchanges
N/A
Address
131 Gasandigital 1-ro, 21st Floor BYC Highcity Building A, Geumcheon-gu, Seoul, KOR, 08506
IMBdx Inc detects and analyzes the genomic profile of tumor DNA with a single draw of blood. It provides personalized and optimized analysis information that can be utilized in therapy selection and monitoring. Its AlphaLiquid platform offers ctDNA-based precision diagnostics solutions across the full continuum of cancer care, from therapy selection (AlphaLiquid 100/HRR) to recurrence and minimal residual disease(MRD) monitoring (CancerDetect), and multi-cancer early detection (CancerFind). Its services are Clinical Service BioPharma, Research, and Healthcare Checkup.

IMBdx Headlines

No Headlines